{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:23:01Z","timestamp":1754558581592,"version":"3.40.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007113","name":"Arak University of Medical Sciences","doi-asserted-by":"publisher","award":["658"],"award-info":[{"award-number":["658"]}],"id":[{"id":"10.13039\/501100007113","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00943-x","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T03:07:17Z","timestamp":1747624037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunomodulatory effects of detoxification agents on dendritic cell populations in methamphetamine addiction"],"prefix":"10.1186","volume":"26","author":[{"given":"Ghasem","family":"Mosayebi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Moazzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadiseh","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Solhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-9594","authenticated-orcid":false,"given":"Ali","family":"Ghazavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"3","key":"943_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/ADM.0b013e31828baede","volume":"7","author":"A Ghazavi","year":"2013","unstructured":"Ghazavi A, et al. Cytokine profiles in long-term smokers of opium (Taryak). J Addict Med. 2013;7(3):200\u20133.","journal-title":"J Addict Med"},{"key":"943_CR2","doi-asserted-by":"crossref","unstructured":"Eisenstein TK. The role of opioid receptors in immune system function. Front Immunol, 2019. 10.","DOI":"10.3389\/fimmu.2019.02904"},{"issue":"1","key":"943_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bja\/aet153","volume":"111","author":"M Al-Hashimi","year":"2013","unstructured":"Al-Hashimi M, et al. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111(1):80\u20138.","journal-title":"Br J Anaesth"},{"key":"943_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","volume":"6","author":"S Roy","year":"2011","unstructured":"Roy S, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6:442\u201365.","journal-title":"J Neuroimmune Pharmacol"},{"key":"943_CR5","doi-asserted-by":"publisher","first-page":"108696","DOI":"10.1016\/j.intimp.2022.108696","volume":"107","author":"G-F Re","year":"2022","unstructured":"Re G-F, et al. Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal. Int Immunopharmacol. 2022;107:108696.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"943_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","volume":"16","author":"H Friedman","year":"2003","unstructured":"Friedman H, Newton C, Klein TW. Microbial infections, Immunomodulation, and drugs of abuse. Clin Microbiol Rev. 2003;16(2):209\u201319.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"943_CR7","first-page":"5","volume":"1","author":"X Liang","year":"2016","unstructured":"Liang X, et al. Opioid system modulates the immune function: A review. Transl Perioper Pain Med. 2016;1(1):5\u201313.","journal-title":"Transl Perioper Pain Med"},{"issue":"3","key":"943_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/jpet.121.000767","volume":"379","author":"DR Miller","year":"2021","unstructured":"Miller DR, et al. Methamphetamine dysregulation of the central nervous system and peripheral immunity. J Pharmacol Exp Ther. 2021;379(3):372\u201385.","journal-title":"J Pharmacol Exp Ther"},{"key":"943_CR9","doi-asserted-by":"crossref","unstructured":"Nicosia N, et al. The economic cost of methamphetamine use in the United States, 2005. Rand Corporation; 2009.","DOI":"10.7249\/MG829"},{"issue":"4","key":"943_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","volume":"162","author":"ND Volkow","year":"2015","unstructured":"Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162(4):712\u201325.","journal-title":"Cell"},{"issue":"40","key":"943_CR11","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1523\/JNEUROSCI.1392-16.2016","volume":"36","author":"M Lin","year":"2016","unstructured":"Lin M, Sambo D, Khoshbouei H. Methamphetamine regulation of firing activity of dopamine neurons. J Neurosci. 2016;36(40):10376\u201391.","journal-title":"J Neurosci"},{"key":"943_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.maturitas.2018.12.003","volume":"121","author":"M Papageorgiou","year":"2019","unstructured":"Papageorgiou M, et al. Methamphetamine and its immune-modulating effects. Maturitas. 2019;121:13\u201321.","journal-title":"Maturitas"},{"issue":"12","key":"943_CR13","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2174\/1570159X19666210428121632","volume":"19","author":"K Macur","year":"2021","unstructured":"Macur K, Ciborowski P. Immune system and methamphetamine: molecular basis of a relationship. Curr Neuropharmacol. 2021;19(12):2067\u201376.","journal-title":"Curr Neuropharmacol"},{"key":"943_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/SAR.S431273","volume":"15","author":"JR Yates","year":"2024","unstructured":"Yates JR. Pharmacological treatments for methamphetamine use disorder: current status and future targets. Subst Abuse Rehabil. 2024;15:125\u201361.","journal-title":"Subst Abuse Rehabil"},{"issue":"5","key":"943_CR15","doi-asserted-by":"publisher","first-page":"e2975","DOI":"10.1002\/brb3.2975","volume":"13","author":"ZM Arani","year":"2023","unstructured":"Arani ZM, et al. Effect of Risperidone on morphine-induced conditioned place preference and dopamine receptor D2 gene expression in male rat hippocampus. Brain Behav. 2023;13(5):e2975.","journal-title":"Brain Behav"},{"issue":"10","key":"943_CR16","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00213-021-05946-0","volume":"238","author":"RR Jaeschke","year":"2021","unstructured":"Jaeschke RR, Sujkowska E, Sowa-Ku\u0107ma M. Methylphenidate for attention-deficit\/hyperactivity disorder in adults: a narrative review. Psychopharmacology. 2021;238(10):2667\u201391.","journal-title":"Psychopharmacology"},{"key":"943_CR17","doi-asserted-by":"crossref","unstructured":"Chiappini S et al. Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. Front Psychiatry, 2024;15\u20132024.","DOI":"10.3389\/fpsyt.2024.1508732"},{"key":"943_CR18","doi-asserted-by":"crossref","unstructured":"van Ruitenbeek P, et al. Methylphenidate as a treatment option for substance use disorder: A transdiagnostic perspective. Front Psychiatry. 2023;14\u20132023.","DOI":"10.3389\/fpsyt.2023.1208120"},{"issue":"6","key":"943_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","volume":"69","author":"L Karila","year":"2010","unstructured":"Karila L, et al. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol. 2010;69(6):578\u201392.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"943_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jsps.2013.04.003","volume":"22","author":"H Solhi","year":"2014","unstructured":"Solhi H, et al. Methylphenidate vs. resperidone in treatment of methamphetamine dependence: A clinical trial. Saudi Pharm J. 2014;22(3):191\u20134.","journal-title":"Saudi Pharm J"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.040","volume":"150","author":"JR Richards","year":"2015","unstructured":"Richards JR, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015;150:1\u201313.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"943_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","volume":"129","author":"WJ Panenka","year":"2013","unstructured":"Panenka WJ, et al. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend. 2013;129(3):167\u201379.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"943_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s43556-023-00125-3","volume":"4","author":"H Cheng","year":"2023","unstructured":"Cheng H, et al. Signaling pathways involved in the biological functions of dendritic cells and their implications for disease treatment. Mol Biomed. 2023;4(1):15.","journal-title":"Mol Biomed"},{"issue":"11","key":"943_CR24","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18(11):2461\u201371.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"943_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete A, et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol. 2023;20(5):432\u201347.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"943_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/life11080801","volume":"11","author":"K-T Tang","year":"2021","unstructured":"Tang K-T, et al. Dendritic cells and antiphospholipid syndrome: an updated systematic review. Life. 2021;11(8):801.","journal-title":"Life"},{"key":"943_CR27","doi-asserted-by":"publisher","first-page":"113541","DOI":"10.1016\/j.biopha.2022.113541","volume":"155","author":"D Wang","year":"2022","unstructured":"Wang D, et al. Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review. Biomed Pharmacother. 2022;155:113541.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"943_CR28","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","volume":"22","author":"KF Bol","year":"2016","unstructured":"Bol KF, et al. Dendritic cell\u2013based immunotherapy: state of the Art and beyond. Clin Cancer Res. 2016;22(8):1897\u2013906.","journal-title":"Clin Cancer Res"},{"issue":"19","key":"943_CR29","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.3889\/oamjms.2019.735","volume":"7","author":"M Gulubova","year":"2019","unstructured":"Gulubova M. Myeloid and plasmacytoid dendritic cells and Cancer - New insights. Open Access Maced J Med Sci. 2019;7(19):3324\u201340.","journal-title":"Open Access Maced J Med Sci"},{"issue":"7","key":"943_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1567-5769(02)00047-4","volume":"2","author":"Q Yu","year":"2002","unstructured":"Yu Q, et al. Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol. 2002;2(7):951\u201362.","journal-title":"Int Immunopharmacol"},{"key":"943_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.intimp.2018.11.047","volume":"66","author":"A Akbari","year":"2019","unstructured":"Akbari A, et al. Methadone therapy modulate the dendritic cells of heroin addicts. Int Immunopharmacol. 2019;66:330\u20135.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"943_CR32","first-page":"216","volume":"13","author":"P Lissoni","year":"1999","unstructured":"Lissoni P, et al. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents. 1999;13(4):216\u20139.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"12","key":"943_CR33","doi-asserted-by":"publisher","first-page":"e49897","DOI":"10.1371\/journal.pone.0049897","volume":"7","author":"R Harms","year":"2012","unstructured":"Harms R, et al. Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression. PLoS ONE. 2012;7(12):e49897.","journal-title":"PLoS ONE"},{"issue":"3","key":"943_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3324\/haematol.2020.268136","volume":"107","author":"N Van Leeuwen-Kerkhoff","year":"2022","unstructured":"Van Leeuwen-Kerkhoff N, et al. Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes. Haematologica. 2022;107(3):655\u201367.","journal-title":"Haematologica"},{"key":"943_CR35","doi-asserted-by":"publisher","first-page":"101372","DOI":"10.1016\/j.tacc.2024.101372","volume":"57","author":"L Lei","year":"2024","unstructured":"Lei L, et al. Research progress on the effects of opioids on the immune system. Trends Anaesth Crit Care. 2024;57:101372.","journal-title":"Trends Anaesth Crit Care"},{"key":"943_CR36","doi-asserted-by":"publisher","first-page":"115417","DOI":"10.1016\/j.bcp.2023.115417","volume":"209","author":"Q Sun","year":"2023","unstructured":"Sun Q, et al. Immunosuppression by opioids: mechanisms of action on innate and adaptive immunity. Biochem Pharmacol. 2023;209:115417.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"943_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.intimp.2011.11.011","volume":"12","author":"ML Chen","year":"2012","unstructured":"Chen ML, et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-\u03b1-directed cell apoptosis in neutrophils. Int Immunopharmacol. 2012;12(1):197\u2013204.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"943_CR38","doi-asserted-by":"publisher","first-page":"e104430","DOI":"10.1371\/journal.pone.0104430","volume":"9","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D, et al. Treatment with the antipsychotic agent, Risperidone, reduces disease severity in experimental autoimmune encephalomyelitis. PLoS ONE. 2014;9(8):e104430.","journal-title":"PLoS ONE"},{"issue":"3","key":"943_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/imm.13127","volume":"158","author":"KA Bain","year":"2019","unstructured":"Bain KA, Milling S. T cell addiction: can pathogenic T cells be controlled using dopamine receptors? Immunology. 2019;158(3):151\u20132.","journal-title":"Immunology"},{"issue":"2","key":"943_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2567.2002.01418.x","volume":"106","author":"AS Morel","year":"2002","unstructured":"Morel AS, Coulton G, Londei M. Regulation of major histocompatibility complex class II synthesis by interleukin-10. Immunology. 2002;106(2):229\u201336.","journal-title":"Immunology"},{"issue":"5","key":"943_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4062\/biomolther.2020.044","volume":"28","author":"B Kim","year":"2020","unstructured":"Kim B, Yun J, Park B. Methamphetamine-Induced neuronal damage: neurotoxicity and neuroinflammation. Biomol Ther (Seoul). 2020;28(5):381\u20138.","journal-title":"Biomol Ther (Seoul)"},{"key":"943_CR42","doi-asserted-by":"publisher","first-page":"984997","DOI":"10.3389\/fphar.2022.984997","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Epigenetic mechanisms involved in methamphetamine addiction. Front Pharmacol. 2022;13:984997.","journal-title":"Front Pharmacol"},{"issue":"4","key":"943_CR43","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1213\/ANE.0000000000005140","volume":"131","author":"JW Zmijewski","year":"2020","unstructured":"Zmijewski JW, Pittet JF. Human leukocyte Antigen-DR deficiency and Immunosuppression-Related End-Organ failure in SARS-CoV2 infection. Anesth Analg. 2020;131(4):989\u201392.","journal-title":"Anesth Analg"},{"issue":"26","key":"943_CR44","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1073\/pnas.1805542115","volume":"115","author":"J Wu","year":"2018","unstructured":"Wu J, et al. Critical role of integrin CD11c in Splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity. Proc Natl Acad Sci U S A. 2018;115(26):6786\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"943_CR45","doi-asserted-by":"crossref","unstructured":"Zapata R et al. Adverse effects of antipsychotic drugs on metabolism depend on drug dosing and feeding times. 2022.","DOI":"10.1101\/2022.02.23.22271365"},{"key":"943_CR46","doi-asserted-by":"publisher","first-page":"1411047","DOI":"10.3389\/fimmu.2024.1411047","volume":"15","author":"MJ Podolska","year":"2024","unstructured":"Podolska MJ, et al. IL-3: key orchestrator of inflammation. Front Immunol. 2024;15:1411047.","journal-title":"Front Immunol"},{"issue":"1","key":"943_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","volume":"50","author":"B Reizis","year":"2019","unstructured":"Reizis B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity. 2019;50(1):37\u201350.","journal-title":"Immunity"},{"key":"943_CR48","doi-asserted-by":"publisher","first-page":"113795","DOI":"10.1016\/j.expneurol.2021.113795","volume":"344","author":"S Jayanthi","year":"2021","unstructured":"Jayanthi S, Daiwile AP, Cadet JL. Neurotoxicity of methamphetamine: main effects and mechanisms. Exp Neurol. 2021;344:113795.","journal-title":"Exp Neurol"},{"issue":"2","key":"943_CR49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0022-3565(25)24408-1","volume":"244","author":"PA Janssen","year":"1988","unstructured":"Janssen PA, et al. Pharmacology of Risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther. 1988;244(2):685\u201393.","journal-title":"J Pharmacol Exp Ther"},{"key":"943_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jsat.2015.11.009","volume":"62","author":"G Wang","year":"2016","unstructured":"Wang G, et al. Aripiprazole and Risperidone for treatment of Methamphetamine-Associated psychosis in Chinese patients. J Subst Abuse Treat. 2016;62:84\u20138.","journal-title":"J Subst Abuse Treat"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00943-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:03:39Z","timestamp":1747627419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00943-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00943-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"type":"electronic","value":"2050-6511"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Arak University of Medical Sciences approved this study (Ethical Code: IR.ARAKMU.REC.1390.113.9) and informed consent to participate was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}